Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Conducting Public Health Research in Kenya (Panel B), Funding Opportunity Announcement (FOA) GH10-003, Initial Review, 30844 [2010-13169]

Download as PDF 30844 Federal Register / Vol. 75, No. 105 / Wednesday, June 2, 2010 / Notices (2) Describe the ability of the organization to manage the proposed project. Include information regarding similarly sized projects in scope and financial assistance as well as other cooperative agreement/grants and projects successfully completed. (3) Describe what equipment (i.e., fax machine, phone, computer, etc.) and facility space (i.e., office space) will be available for use during the proposed project. Include information about any equipment not currently available that will be purchased through the cooperative agreement/grant. (4) List key personnel who will work on the project. Include title used in the work-plan. In the appendix, include position descriptions and resumes for all key personnel. Position descriptions should clearly describe each position and duties, indicating desired qualifications and experience requirements related to the proposed project. Resumes must indicate that the proposed staff member is qualified to carry out the proposed project activities. If a position is to be filled, indicate that information on the proposed position description. (5) Address the extent to which the proposed project will build the organization’s capacity to provide, improve, or expand services that address the need(s) of the target population. sroberts on DSKD5P82C1PROD with NOTICES C. Categorical Budget and Budget Justification (15 Points) (1) Provide a categorical budget for each supplement based on the project period identified. (2) If indirect costs are claimed, indicate and apply the current negotiated rate to the budget. Include a copy of the rate agreement in the appendix. (3) Provide a narrative justification explaining why each line item is necessary/relevant to the proposed project. Include sufficient cost and other details to facilitate the determination of cost allowability (i.e., equipment specifications, etc.). D. Project Evaluation (15 Points) Each proposed objective requires an evaluation component to assess its progression and ensure its completion. Also, include the evaluation activities in the work-plan. Describe the proposed plan to evaluate both outcomes and process. Outcome evaluation relates to the results identified in the objectives, and process evaluation relates to the work-plan and activities of the project. (1) For outcome evaluation, describe: • What the criteria will be for determining success of each objective. VerDate Mar<15>2010 19:08 Jun 01, 2010 Jkt 220001 • What data will be collected to determine whether the objective was met. • At what intervals will data be collected. • Who will collect the data and their qualifications. • How the data will be analyzed. • How the results will be used. (2) For process evaluation, describe: • How the project will be monitored and assessed for potential problems and needed quality improvements. • Who will be responsible for monitoring and managing project improvements based on results of ongoing process improvements and their qualifications. • How ongoing monitoring will be used to improve the project. • Any products, such as manuals or policies, that might be developed and how they might lend themselves to replication by others. • How the project will document what is learned throughout the project period. (3) Describe any evaluation efforts that are planned to occur after the grant period ends. (4) Describe the ultimate benefit for the AI/AN that will be derived from this project. Agency Contact(s): For program-related information, contact Ronald Demaray, Acting Director, IHS Office of Direct Service and Contracting Tribes, phone number 301–443–1104 or by e-mail at ronald.demaray@ihs.gov. For grants-related information, contact Kimberly M. Pendleton, Grants Management Officer, Division of Grants Operations, 301–443–5204 or by e-mail at kimberly.pendleton@ihs.gov. Dated: May 26, 2010. Randy Grinnell, Deputy Director, Indian Health Service. Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 12 p.m.–3 p.m., June 24, 2010 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Conducting Public Health Research in Kenya (Panel B),’’ FOA GH10– 003. Contact Person for More Information: Sheree Marshall Williams, PhD, Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D73, Atlanta, GA 30333, Telephone: (404) 639–7742. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 25, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–13169 Filed 6–1–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2007–F–0330] (formerly Docket No. 2007F–0454) General Mills, Inc.; Withdrawal of Food Additive Petition AGENCY: Food and Drug Administration, HHS. ACTION: Notice. [FR Doc. 2010–13148 Filed 6–1–10; 8:45 am] BILLING CODE 4165–16–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Conducting Public Health Research in Kenya (Panel B), Funding Opportunity Announcement (FOA) GH10–003, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 SUMMARY: The Food and Drug Administration (FDA) is announcing the withdrawal, without prejudice to a future filing, of a food additive petition (FAP 7M4770) proposing that the food additive regulations be amended to provide for the safe use of ultraviolet radiation for the reduction of pathogens and other microorganisms in aqueous sugar solutions and potable water intended for use in food production. FOR FURTHER INFORMATION CONTACT: Laura A. Dye, Center for Food Safety and Applied Nutrition (HFS–265), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740– 3835, 301–436–1275. SUPPLEMENTARY INFORMATION: In a notice published in the Federal Register of E:\FR\FM\02JNN1.SGM 02JNN1

Agencies

[Federal Register Volume 75, Number 105 (Wednesday, June 2, 2010)]
[Notices]
[Page 30844]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-13169]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Conducting Public Health Research in Kenya (Panel 
B), Funding Opportunity Announcement (FOA) GH10-003, Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 12 p.m.-3 p.m., June 24, 2010 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Conducting Public Health Research in Kenya (Panel 
B),'' FOA GH10-003.
    Contact Person for More Information: Sheree Marshall Williams, 
PhD, Scientific Review Administrator, CDC, 1600 Clifton Road, NE., 
Mailstop D73, Atlanta, GA 30333, Telephone: (404) 639-7742.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 25, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-13169 Filed 6-1-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.